Encompass Health Corp - Common Stock (EHC)

Historical Holders from Q1 2016 to Q3 2025

Symbol: EHC on NYSE
Type / Class: Equity / Common Stock
Shares outstanding: 100,761,050
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 93,679,017
Holdings value: $11,895,118,967
% of all portfolios: 0.01%
Number of holders: 598
Number of buys: 286
Number of sells: -283
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Encompass Health Corp - Common Stock (EHC)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
WELLINGTON MANAGEMENT GROUP LLP	4%		$456,931,210		4,030,442		Wellington Management Group LLP	31 Dec 2024

Institutional Holders of Encompass Health Corp - Common Stock (EHC)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	93,679,017	$11,895,118,967	-$143,150,843	$6,528,828	$8,970,424	$127.02	598
2025 Q2	94,968,235	$11,642,879,160	-$49,112,078	$1,802,661	$12,650,084	$122.63	603
2025 Q1	95,615,973	$9,683,390,579	+$19,223,151	$12,751,456	$10,583,760	$101.28	534
2024 Q4	95,688,892	$8,837,272,246	-$61,337,557	$3,860,398	$10,056,915	$92.35	540
2024 Q3	95,659,986	$9,240,740,107	-$28,092,689	$4,849,249	$13,452,288	$96.64	478
2024 Q2	95,815,590	$8,220,005,999	-$60,422,230	$6,571,514	$9,994,535	$85.79	476
2024 Q1	97,703,422	$8,070,672,559	+$16,673,851	$70,448,998	$45,741,062	$82.58	433
2023 Q4	97,223,556	$6,487,871,907	+$126,291,067	$1,334,400	$4,043,232	$66.72	429
2023 Q3	94,211,639	$6,326,664,657	+$24,828,296	$4,573,596	$5,782,476	$67.16	410
2023 Q2	93,484,125	$6,330,038,243	+$9,034,551	$14,699,840	$6,771,000	$67.71	380
2023 Q1	93,612,402	$5,065,388,681	-$121,237,618	$2,483,190	$61,803,900	$54.1	384
2022 Q4	96,070,844	$5,746,729,705	+$9,797,176	$412,689	$4,814,478	$59.81	368
2022 Q3	96,958,614	$4,388,175,997	+$140,328,300	$2,235,000	$15,344,000	$45.23	325
2022 Q2	91,599,655	$5,129,979,182	-$75,940,650	$10,802,000	$12,309,000	$56.05	367
2022 Q1	94,188,292	$6,688,146,207	+$180,281,875	$19,743,000	$55,076,000	$71.11	399
2021 Q4	91,512,815	$5,963,921,386	-$30,961,306	$25,958,512	$100,782,646	$65.26	397
2021 Q3	91,185,917	$6,852,134,068	-$52,652,075	$17,455,000	$99,385,000	$75.04	430
2021 Q2	91,493,382	$7,141,491,218	+$213,843	$10,294,000	$46,108,000	$78.03	409
2021 Q1	92,312,962	$7,562,692,331	+$3,926,033	$12,784,000	$24,918,000	$81.9	398
2020 Q4	92,274,413	$7,632,521,664	-$63,397,436	$13,841,000	$23,708,000	$82.69	396
2020 Q3	92,464,254	$6,004,059,199	+$39,210,352	$3,626,000	$27,830,000	$64.98	367
2020 Q2	91,927,091	$5,693,124,070	+$51,792,099	$6,094,000	$18,337,000	$61.93	368
2020 Q1	91,105,048	$5,833,264,260	+$52,464,250	$19,096,000	$29,313,000	$64.03	364
2019 Q4	90,001,581	$6,236,071,239	+$91,472,066	$20,774,000	$21,980,000	$69.27	386
2019 Q3	88,484,154	$5,598,476,445	-$18,802,705	$9,264,000	$4,037,000	$63.28	347
2019 Q2	89,198,111	$5,639,749,550	+$7,601,931	$11,570,000	$6,408,000	$63.36	384
2019 Q1	90,121,856	$5,247,040,194	+$18,787,364	$12,767,000	$6,301,000	$58.4	411
2018 Q4	89,690,946	$5,514,671,892	+$22,743,172	$9,132,000	$14,191,000	$61.7	431
2018 Q3	89,001,044	$6,908,383,556	-$123,374,722	$18,810,000	$21,141,000	$77.95	420
2018 Q2	90,646,004	$6,113,554,537	-$37,690,220	$1,707,000	$2,445,000	$67.72	377
2018 Q1	91,402,381	$5,203,639,355	+$4,844,225,974	$1,143,000	$4,283,000	$57.17	346
2017 Q4	6,107,530	$301,944,000	+$263,780,365	$3,923,000		$49.41	40
2017 Q3	86	$3,000	+$663			$34.88	1
2017 Q2	67	$3,000				$44.78	1
2017 Q1	67	$2,000	-$776			$29.85	1
2016 Q4	93	$3,000	+$1,387			$32.26	1
2016 Q3	50	$2,000				$40	1
2016 Q2	50	$1,000	-$1,120			$20	1
2016 Q1	73	$3,000	+$2,000			$47.27	2